Telix: A masterclass in what this game is all about

Today's market darling reminds us why we love to invest. But is it too late?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Every now and again, an ASX company emerges that captures the hearts and minds of investors. 

It doesn't happen every year, but it certainly happens more often than you think. 

From Droneshield (ASX: DRO) to ProMedicus (ASX: PME) to Supply Network (ASX: SNL), these companies have all produced total returns in excess of 700% over the last 5 years. 

The latest market darling is, of course, none other than Telix Pharmaceuticals (ASX: TLX). 

Just 5 years ago, the company reported revenue of $3.5m and now its 2025 sales guidance is in excess of $1.2 billion (US$785m at the midpoint), a phenomenal 343x increase! 

Its share price has done alright, just a lazy 25x increase over the same period. 

It's the stuff that dreams are made of, and it reminds us why we love this game of investing. 

Now, if you cut out the hype, there are actually important investing lessons to learn from Telix.

A boy is excited because he won the computer game.

Image source: Getty Images

Stay optimistic and always look forward 

Five years ago, we were in the midst of a pandemic, and the world was facing a lot of uncertainty. (Not much has changed!). 

It would have been easy to ignore a small, speculative pharmaceutical company with $3.5m in revenue, but investing is all about looking ahead, imagining all the different possibilities, and pricing them accordingly. 

No matter what the headlines say, the share market will surprise you with the opportunities that it can create. Stay optimistic, always look forward. 

Business fundamentals matter

A 25x share price return is nice, but the real story here is the 343x increase in sales. Students of the game know how important it is to study the business and its fundamentals. 

The context matters too. Sales growth may be important for Telix now as a growth company, but perhaps at some point in the future, earnings per share and free cash flow will become more important metrics. 

Tough times will come 

Sorry to be the bearer of bad news, but tough times will eventually come. At some point, Telix shareholders will have to deal with a major share price decline. It could be up to a 20% decline, or it could be a lot more. 

It happens to every market darling, and it's just the nature of the beast. 

The time to mentally prepare yourself and work out what you would do in such a scenario is now. Write down your game plan, explain your rationale, and constantly re-evaluate it using the business fundamentals as your guide. Tough times will eventually come. 

You don't need a Telix to do well

Telix's monster returns are worth celebrating; this is a company solving real-world problems after all. But let me be clear: you don't need Telix to do well in the share market. 

I say this because it's natural for investors who have missed out on Telix to have that fear of missing out (FOMO). If that's you, remember that there are plenty of opportunities out there. 

They won't all do as well as Telix, but even a 2x return in 5 years (just short of a 15% compounded annual growth rate) is a great return. 

Find the next Telix 

Finally, it's of no use to just look back at Telix's success without applying the lessons to help us find the next Telix. Ultimately, finding winning companies is what this game is all about. That's why we love it. 

If you need some help doing that, I know a band of merry Fools who just might be able to help…

Motley Fool contributor Kevin Gandiya has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Supply Network Ltd, and Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus, Supply Network Ltd, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Brazilian Rare Earths, L1 Group, Silver Mines, and Xero shares are dropping today

These shares are having a poor session on Thursday. But why?

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Resources Shares

3 ASX mining shares: Buy, hold, or sell?

ASX 300 mining shares have fallen 16% since the conflict in Iran began.

Read more »

Happy man standing in front of an oil rig.
Broker Notes

Why this sold-off ASX energy stock could rise 60%+

Bell Potter is tipping this stock as a buy following a sell-off this week.

Read more »

Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.
Share Market News

Vault Minerals: KoTH plant upgrade commissioning kicks off

Vault Minerals has started commissioning the first stage of its major King of the Hills plant upgrade, keeping the project…

Read more »

A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.
Share Market News

Sims Group earnings: SLS now core to growth

Sims Group’s SLS business now accounts for 40% of earnings and is driving strong growth with hyperscaler partners.

Read more »

a man sits on his sofa loong at his phone and raises a fist to the air in happy celebration.
Share Market News

Infratil lifts CDC outlook and FY27 earnings guidance

Infratil lifted its CDC earnings guidance and expanded its data centre operations in response to robust sector demand.

Read more »

A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
Share Market News

How long will it take for the ASX 200 to recover? Expert

A recent Betashares report explored how long similar falls in the past have taken to recover.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what you need to know ahead of today's session.

Read more »